Article Figures & Data
Figures
- Figure 1.
Photographs of granular hydroxyapatite before implantation (A) and in alveolar socket post-implantation (B). Scanning electron microscope image of porous HA (pHA) scaffold (C) and photograph of aseptically prepared pHA before implantation (D).
- Figure 2.
Levels of bone mineral density (BMD) in canine alveolar cavity at 8 weeks post-implantation. Mean±SD (n=4), *p<0.05.
- Figure 3.
Percentages of bone volume (BV)/tissue volume (TV) in canine alveolar cavity at 8 weeks post-implantation. Mean±SD (n=4), *p<0.05.
- Figure 4.
Micro-computed tomography photos of grafting treated with granular hydroxyapatite in canine alveolar socket at 8 weeks post-implantation. Microcomputed tomography in transaxial (A), sagittal (B), coronal (C) axes, and 3D (D).
- Figure 5.
Micro-Ct photos of grafting treated with porous HA scaffold in canine alveolar socket at 8 weeks post-implantation. Micro-computed tomography in transaxial (A), sagittal (B), coronal (C) axes, and 3D (D).
- Figure 6.
Fluorescence microscopic images of granular hydroxyapatite (gHA) and porous HA (pHA) in canine alveolar sockets at 8 weeks post-implantation. Yellow (oxytetracycline), green (calcein) and red (alizarin) indicated new bone formation after implantation under confocal microscopy.
